| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |